Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance

被引：0
|
作者：
Ramesh Pothuraju
Satyanarayana Rachagani
Shiv Ram Krishn
Sanjib Chaudhary
Rama Krishna Nimmakayala
Jawed A. Siddiqui
Koelina Ganguly
Imayavaramban Lakshmanan
Jesse L. Cox
Kavita Mallya
Sukhwinder Kaur
Surinder K. Batra
机构：
[1] University of Nebraska Medical Center,Department of Biochemistry and Molecular Biology
[2] University of Nebraska Medical Center,Department of Pathology and Microbiology
[3] University of Nebraska Medical Center,Fred and Pamela Buffett Cancer Center
[4] University of Nebraska Medical Center,Eppley Institute for Research in Cancer and Allied Diseases
来源：
Molecular Cancer | / 19卷
关键词：
Mucins; MUC5AC; CD44; β-Catenin; Colon cancer; Colorectal cancer; 5′-fluorouracil; Chemoresistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance
    Pothuraju, Ramesh
    Rachagani, Satyanarayana
    Krishn, Shiv Ram
    Chaudhary, Sanjib
    Nimmakayala, Rama Krishna
    Siddiqui, Jawed A.
    Ganguly, Koelina
    Lakshmanan, Imayavaramban
    Cox, Jesse L.
    Mallya, Kavita
    Kaur, Sukhwinder
    Batra, Surinder K.
    MOLECULAR CANCER, 2020, 19 (01)
  • [2] MUC1 and MUC5AC implication in Tunisian colorectal cancer patients
    Hazgui, Meriam
    Weslati, Marwa
    Boughriba, Rahma
    Ounissi, Donia
    Bacha, Dhouha
    Bouraoui, Saadia
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (01) : 309 - 318
  • [3] The role of Nrf2-Keap1 axis in colorectal cancer, progression, and chemoresistance
    Sadeghi, Mohammad Reza
    Jeddi, Farhad
    Soozangar, Narges
    Somi, Mohammad Hossein
    Samadi, Nasser
    TUMOR BIOLOGY, 2017, 39 (06)
  • [4] Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma
    Bu, Xiao-Dong
    Li, Nan
    Tian, Xiao-Qiang
    Li, Li
    Wang, Jin-Song
    Yu, Xiao-Jin
    Huang, Pei-Lin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (32) : 4089 - 4094
  • [5] MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer
    Cozzi, PJ
    Wang, J
    Delprado, W
    Perkins, AC
    Allen, BJ
    Russell, PJ
    Li, Y
    CLINICAL & EXPERIMENTAL METASTASIS, 2005, 22 (07) : 565 - 573
  • [6] MUC1, MUC2, MUC4, MUC5AC and MUC6 Expression in the Progression of Prostate Cancer
    Paul J. Cozzi
    Jian Wang
    Warick Delprado
    Alan C. Perkins
    Barry J. Allen
    Pamela J. Russell
    Yong Li
    Clinical & Experimental Metastasis, 2005, 22 : 565 - 573
  • [7] YAP Promotes Chemoresistance to 5-FU in Colorectal Cancer Through mTOR/GLUT3 Axis
    Xu, Qixuan
    Jin, Zhesi
    Yuan, Zhen
    Yu, Zhiyuan
    Gao, Jingwang
    Zhao, Ruiyang
    Li, Hanghang
    Ren, Huiguang
    Cao, Bo
    Wei, Bo
    Jiang, Linhua
    JOURNAL OF CANCER, 2024, 15 (20): : 6784 - 6797
  • [8] MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
    Betge, Johannes
    Schneider, Nora I.
    Harbaum, Lars
    Pollheimer, Marion J.
    Lindtner, Richard A.
    Kornprat, Peter
    Ebert, Matthias P.
    Langner, Cord
    VIRCHOWS ARCHIV, 2016, 469 (03) : 255 - 265
  • [9] Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancer
    Rico, Sebastian Dwertmann
    Hoflmayer, Doris
    Buscheck, Franziska
    Dum, David
    Luebke, Andreas M.
    Kluth, Martina
    Hube-Magg, Claudia
    Hinsch, Andrea
    Moller-Koop, Christina
    Perez, Daniel
    Izbicki, Jakob R.
    Neipp, Michael
    Mofid, Hamid
    Larusson, Hannes
    Daniels, Thies
    Isbert, Christoph
    Coerper, Stephan
    Ditterich, Daniel
    Rupprecht, Holger
    Goetz, Albert
    Fraune, Christoph
    Moller, Katharina
    Menz, Anne
    Bernreuther, Christian
    Clauditz, Till S.
    Sauter, Guido
    Uhlig, Ria
    Wilczak, Waldemar
    Simon, Ronald
    Steurer, Stefan
    Lebok, Patrick
    Burandt, Eike
    Krech, Till
    Marx, Andreas H.
    MEDICAL MOLECULAR MORPHOLOGY, 2021, 54 (02) : 156 - 165
  • [10] EpCAM is critical for tumor proliferation and oxaliplatin chemoresistance in EpCAMhigh/CD44+ colorectal cancer stem cells
    Qi, Yanmei
    Zhou, Fengqiang
    Geng, Zhen
    Ding, Baozhong
    Liu, Lei
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2022, 47 (05): : 620 - 625
12345